In 2023, the re-import of penicillins to Canada was valued at approximately 22.78 thousand US dollars. The forecasted data from 2024 to 2028 indicates a steady growth with an approximate average annual growth rate (CAGR) of 5.38%. Year-on-year, the values are expected to increase by around 5.98% on average over the next five years, reflecting a consistent upward trend.

Future trends to watch for include:

Potential changes in global pharmaceutical supply chains, which could impact re-import prices.
Regulatory changes impacting drug imports or exports, affecting cost and availability.
Market dynamics related to demand for antibiotics and emerging alternatives.